{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:16:48Z","timestamp":1790111808342,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T00:00:00Z","timestamp":1455494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s11916-016-0545-0","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T08:33:35Z","timestamp":1455525215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Botulinum Toxin: Pharmacology and Therapeutic Roles in Pain States"],"prefix":"10.1007","volume":"20","author":[{"given":"Shilpadevi","family":"Patil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Willett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terin","family":"Thompkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathish","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse M.","family":"Cornett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan David","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,15]]},"reference":[{"issue":"8","key":"545_CR1","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/WNL.53.8.1850","volume":"53","author":"FJ Erbguth","year":"1999","unstructured":"Erbguth FJ, Naumann M. Historical aspects of botulinum toxin: Justinus Kerner (1786-1862) and the \u2018sausage poison\u2019. Neurology. 1999;53(8):1850\u20133.","journal-title":"Neurology"},{"issue":"2","key":"545_CR2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/infdis\/43.2.152","volume":"43","author":"PT Snipe","year":"1928","unstructured":"Snipe PT, Sommer H. Studies on botulinus toxin: 3. Acid precipitation of botulinus toxin. J Infect Dis. 1928;43(2):152\u201360.","journal-title":"J Infect Dis"},{"issue":"2681","key":"545_CR3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1126\/science.103.2681.613","volume":"103","author":"C Lamanna","year":"1946","unstructured":"Lamanna C, McElroy OE, Eklund HW. The purification and crystallization of clostridium botulinum type A toxin. Science. 1946;103(2681):613\u20134.","journal-title":"Science"},{"issue":"1\u20132","key":"545_CR4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1113\/jphysiol.1949.sp004364","volume":"109","author":"ASV Burgen","year":"1949","unstructured":"Burgen ASV, Dickens F, Zatman LJ. The action of botulinum toxin on the neuro-muscular junction. J Physiol. 1949;109(1\u20132):10\u201324.","journal-title":"J Physiol"},{"key":"545_CR5","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1002\/(SICI)1097-4598(1997)6+<129::AID-MUS9>3.0.CO;2-B","volume":"6","author":"J Jankovic","year":"1997","unstructured":"Jankovic J, Brin MF. Botulinum toxin: historical perspective and potential new indications. Muscle Nerve Suppl. 1997;6:S129\u201345.","journal-title":"Muscle Nerve Suppl"},{"issue":"3","key":"545_CR6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2165\/00126839-200809030-00002","volume":"9","author":"AJ Dowson","year":"2008","unstructured":"Dowson AJ, Kilminster SG, Salt R. Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting. Drugs R & D. 2008;9(3):147\u201358.","journal-title":"Drugs R & D"},{"issue":"6 Suppl","key":"545_CR7","first-page":"S142","volume":"18","author":"MF Lew","year":"2002","unstructured":"Lew MF. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction. Clin J Pain. 2002;18(6 Suppl):S142\u20136.","journal-title":"Clin J Pain"},{"issue":"1","key":"545_CR8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/0019-5154.60343","volume":"55","author":"PK Nigam","year":"2010","unstructured":"Nigam PK, Nigam A. Botulinum toxin. Indian J Dermatol. 2010;55(1):8\u201314.","journal-title":"Indian J Dermatol"},{"issue":"3","key":"545_CR9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.rcae.2014.04.004","volume":"42","author":"RC Rivera D\u00eda","year":"2014","unstructured":"Rivera D\u00eda RC, Lotero MAA, Suarez MVA, Saldarriaga SE, Mart\u00ednez MG. Botulinum toxin for the treatment of chronic pain. Review of the evidence. Colomb J Anesthesiol. 2014;42(3):205\u201313.","journal-title":"Colomb J Anesthesiol"},{"issue":"1","key":"545_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3344\/kjp.2011.24.1.1","volume":"24","author":"WS Sim","year":"2011","unstructured":"Sim WS. Application of botulinum toxin in pain management. Korean J Pain. 2011;24(1):1\u20136.","journal-title":"Korean J Pain"},{"issue":"2","key":"545_CR11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/2042533312472115","volume":"4","author":"R Persaud","year":"2013","unstructured":"Persaud R, Garas G, Silva S, Stamatoglou C, Chatrath P, Patel K. An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions. JRSM Short Rep. 2013;4(2):10.","journal-title":"JRSM Short Rep"},{"issue":"2","key":"545_CR12","first-page":"92","volume":"153","author":"S Yin","year":"2001","unstructured":"Yin S, Stucker FJ, Nathan CA. Clinical application of botulinum toxin in otolaryngology, head and neck practice (brief review). J La State Med Soc. 2001;153(2):92\u20137.","journal-title":"J La State Med Soc"},{"key":"545_CR13","doi-asserted-by":"crossref","unstructured":"Schmitt WJ, Slowey E, Fravi N, Weber S, Burgunder JM. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache. 2001;41(7):658\u201364.","DOI":"10.1046\/j.1526-4610.2001.041007658.x"},{"issue":"4","key":"545_CR14","first-page":"263","volume":"50","author":"M Oliver","year":"2006","unstructured":"Oliver M, MacDonald J, Rajwani M. The use of botulinum neurotoxin type A (Botox) for headaches: a case review. J Can Chiropr Assoc. 2006;50(4):263\u201370.","journal-title":"J Can Chiropr Assoc"},{"issue":"5","key":"545_CR15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/ICU.0b013e3282be9032","volume":"18","author":"A Cetinkaya","year":"2007","unstructured":"Cetinkaya A, Brannan PA. What is new in the era of focal dystonia treatment? Botulinum injections and more. Curr Opin Ophthalmol. 2007;18(5):424\u20139.","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"545_CR16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1067\/mhn.2000.105997","volume":"122","author":"SF Ahsan","year":"2000","unstructured":"Ahsan SF, Meleca RJ, Dworkin JP. Botulinum toxin injection of the cricopharyngeus muscle for the treatment of dysphagia. Otolaryngol Head Neck Surg. 2000;122(5):691\u20135.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"545_CR17","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/toxins5051010","volume":"5","author":"AA Lakraj","year":"2013","unstructured":"Lakraj AA, Moghimi N, Jabbari B. Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins (Basel). 2013;5(5):1010\u201331.","journal-title":"Toxins (Basel)"},{"issue":"1","key":"545_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1875-595X.2011.00085.x","volume":"62","author":"H Long","year":"2012","unstructured":"Long H, Liao Z, Wang Y, Liao L, Lai W. Efficacy of botulinum toxins on bruxism: an evidence-based review. Int Dent J. 2012;62(1):1\u20135.","journal-title":"Int Dent J"},{"issue":"3","key":"545_CR19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00702-014-1278-z","volume":"122","author":"K Kollewe","year":"2015","unstructured":"Kollewe K, Mohammadi B, K\u00f6hler S, Pickenbrock H, Dengler R, Dressler D. Blepharospasm: long-term treatment with either Botox\u00ae, Xeomin\u00ae or Dysport\u00ae. J Neural Transm. 2015;122(3):427\u201331.","journal-title":"J Neural Transm"},{"issue":"7","key":"545_CR20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/jnnp.49.7.827","volume":"49","author":"JS Elston","year":"1986","unstructured":"Elston JS. Botulinum toxin treatment of hemifacial spasm. J Neurol Neurosurg Psychiatry. 1986;49(7):827\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"545_CR21","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.3390\/toxins7083127","volume":"7","author":"H-M Oh","year":"2015","unstructured":"Oh H-M, Chung ME. Botulinum toxin for neuropathic pain: a review of the literature. Toxins (Basel). 2015;7(8):3127\u201354. This article discusses recent advances in botulinum toxin therapy for pain. It discusses recent mechanistic insights and summarizes both clinical and experimental evidence for the use of botulinum toxin to treat pain. The illustrated figure discussing the mechanism of peripheral and central nervous system sensitization included in this manuscript is especially useful.","journal-title":"Toxins (Basel)"},{"issue":"1\u20133","key":"545_CR22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2010.01.020","volume":"633","author":"L Bach-Rojecky","year":"2010","unstructured":"Bach-Rojecky L, Salkovi\u0107-Petrisi\u0107 M, Lackovi\u0107 Z. Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection. Eur J Pharmacol. 2010;633(1\u20133):10\u20134.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"545_CR23","first-page":"323","volume":"13","author":"MR Emad","year":"2011","unstructured":"Emad MR, Emad M, Taheri P. The efficacy of intradermal injection of botulinum toxin in patients with post-herpetic neuralgia. Iran Red Crescent Med J. 2011;13(5):323\u20137.","journal-title":"Iran Red Crescent Med J"},{"issue":"3","key":"545_CR24","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.tripleo.2009.03.021","volume":"109","author":"WC Ngeow","year":"2010","unstructured":"Ngeow WC, Nair R. Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109(3):e47\u201350.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"10","key":"545_CR25","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/j.1526-4610.2008.01089.x","volume":"48","author":"M Taylor","year":"2008","unstructured":"Taylor M, Silva S, Cottrell C. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study. Headache. 2008;48(10):1476\u201381.","journal-title":"Headache"},{"issue":"5","key":"545_CR26","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/STROKEAHA.110.582197","volume":"42","author":"LC Shaw","year":"2011","unstructured":"Shaw LC, Price CIM, van Wijck FMJ, Shackley P, Steen N, Barnes MP, et al. Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain. Stroke. 2011;42(5):1371\u20139.","journal-title":"Stroke"},{"issue":"7","key":"545_CR27","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.parkreldis.2009.11.011","volume":"16","author":"JJG Rath","year":"2010","unstructured":"Rath JJG, Tavy DLJ, Wertenbroek AAACM, van Woerkom TCAM, de Bruijn SFTM. Botulinum toxin type A in simple motor tics: short-term and long-term treatment-effects. Parkinsonism Relat Disord. 2010;16(7):478\u201381.","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"545_CR28","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1185\/030079904125003962","volume":"20","author":"M Naumann","year":"2004","unstructured":"Naumann M, Jankovic J. Safety of botulinum toxin type A: a systematic review and meta-analysis. Curr Med Res Opin. 2004;20(7):981\u201390.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"545_CR29","first-page":"140","volume":"44","author":"MA Chang","year":"2015","unstructured":"Chang MA. Possible adverse effects of repeated botulinum toxin a injections to decrease post-stroke spasticity in adults undergoing rehabilitation: a review of the literature. J Allied Health. 2015;44(3):140\u20134. This manuscript discusses the complications that can arise from using botulinum toxin as a treatment therapy. This is a comprehensive review which includes a discussion of manuscripts from several scientific databases regarding the local and systemic effects of repeated botulinum toxin treatments.","journal-title":"J Allied Health"},{"issue":"1","key":"545_CR30","first-page":"1","volume":"50","author":"M Li","year":"2005","unstructured":"Li M, Goldberger BA, Hopkins C. Fatal case of BOTOX\u00ae-related anaphylaxis? J Forensic Sci. 2005;50(1):1\u20134.","journal-title":"J Forensic Sci"},{"issue":"9","key":"545_CR31","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00702-015-1384-6","volume":"122","author":"A Baricich","year":"2015","unstructured":"Baricich A, Grana E, Carda S, Santamato A, Cisari C, Invernizzi M. High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis. J Neural Transm. 2015;122(9):1283\u20137. This recent article sheds light on the somewhat controversial use of high-dose botulinum toxin as an effective and safe treatment for upper and lower limb post-stroke spasticity.","journal-title":"J Neural Transm"},{"issue":"5","key":"545_CR32","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.urology.2014.07.046","volume":"84","author":"U Nuanthaisong","year":"2014","unstructured":"Nuanthaisong U, Abraham N, Goldman HB. Incidence of adverse events after high doses of onabotulinumtoxinA for multiple indications. Urology. 2014;84(5):1044\u20138.","journal-title":"Urology"},{"key":"545_CR33","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.2147\/DDDT.S79193","volume":"9","author":"WH Jost","year":"2015","unstructured":"Jost WH, Benecke R, Hauschke D, Jankovic J, Ka\u0148ovsk\u00fd P, Roggenk\u00e4mper P, et al. Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders. Drug Des Devel Ther. 2015;9:1913\u201326. This article is a review of data from clinical trials involving botulinum toxin as a treatment therapy. The goal of this review was to summarize data from clinical trials in order to optimize the physician\u2019s use of botulinum toxin as a tailored treatment to individuals for specific conditions by altering the formulation, dose, and treatment intervals of the toxin.","journal-title":"Drug Des Devel Ther"},{"issue":"10","key":"545_CR34","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0333102414561873","volume":"35","author":"E Cernuda-Morollon","year":"2014","unstructured":"Cernuda-Morollon E, Ramon C, Larrosa D, Alvarez R, Riesco N, Pascual J. Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: what happens after 1\u00a0year? Cephalalgia. 2014;35(10):864\u20138.","journal-title":"Cephalalgia"},{"issue":"1\u20132","key":"545_CR35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3959(99)00264-X","volume":"85","author":"M Porta","year":"2000","unstructured":"Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain. 2000;85(1\u20132):101\u20135.","journal-title":"Pain"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-016-0545-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-016-0545-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-016-0545-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T15:52:03Z","timestamp":1567612323000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-016-0545-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,15]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["545"],"URL":"https:\/\/doi.org\/10.1007\/s11916-016-0545-0","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,15]]},"article-number":"15"}}